Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Z Leder

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Acute decline in serum sclerostin in response to PTH infusion in healthy menElaine W Yu, Ruchit Kumbhani, Erica Siwila-Sackman, et al.
The Journal of Clinical Endocrinology and Metabolism|March 21, 2014
FSH suppression does not affect bone turnover in eugonadal menAlexander V Uihlein, Joel S Finkelstein, Hang Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2019
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCTSabashini K Ramchand, Natalie L David, Benjamin Z Leder, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2008
Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of menAndre B Araujo, Thomas G Travison, Benjamin Z Leder, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
Racial and ethnic differences in bone turnover markers in menBenjamin Z Leder, Andre B Araujo, Thomas G Travison, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levelsBenjamin Z Leder, Jacqueline L Rohrer, Stephen D Rubin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 26, 2019
A Lot of Progress, With More to Be Done: A Response to NIH Pathways to Prevention Report "Research Gaps for Long-Term Drug Therapies for Osteoporotic Fracture Prevention"Benjamin Z Leder, Bart L Clarke, Elizabeth Shane, et al.
The Lancet. Diabetes & Endocrinology|August 27, 2019
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trialJoy N Tsai, Hang Lee, Natalie L David, et al.
The Journal of Clinical Endocrinology and Metabolism|June 10, 2020
ERRATUMERRATUM for "Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis"Benjamin Z Leder, Bruce Mitlak, Ming-Yi Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levelsSherri-Ann M Burnett-Bowie, Elizabeth A McKay, Hang Lee, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Acute decline in serum sclerostin in response to PTH infusion in healthy menElaine W Yu, Ruchit Kumbhani, Erica Siwila-Sackman, et al.
The Journal of Clinical Endocrinology and Metabolism|March 21, 2014
FSH suppression does not affect bone turnover in eugonadal menAlexander V Uihlein, Joel S Finkelstein, Hang Lee, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2019
Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCTSabashini K Ramchand, Natalie L David, Benjamin Z Leder, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2008
Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of menAndre B Araujo, Thomas G Travison, Benjamin Z Leder, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
Racial and ethnic differences in bone turnover markers in menBenjamin Z Leder, Andre B Araujo, Thomas G Travison, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levelsBenjamin Z Leder, Jacqueline L Rohrer, Stephen D Rubin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 26, 2019
A Lot of Progress, With More to Be Done: A Response to NIH Pathways to Prevention Report "Research Gaps for Long-Term Drug Therapies for Osteoporotic Fracture Prevention"Benjamin Z Leder, Bart L Clarke, Elizabeth Shane, et al.
The Lancet. Diabetes & Endocrinology|August 27, 2019
Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trialJoy N Tsai, Hang Lee, Natalie L David, et al.
The Journal of Clinical Endocrinology and Metabolism|June 10, 2020
ERRATUMERRATUM for "Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis"Benjamin Z Leder, Bruce Mitlak, Ming-Yi Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levelsSherri-Ann M Burnett-Bowie, Elizabeth A McKay, Hang Lee, et al.
Pageof 9